These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

385 related items for PubMed ID: 22535516

  • 1. Impact of glomerular filtration estimate on bleeding risk in very old patients treated with vitamin K antagonists. Results of EPICA study on the behalf of FCSA (Italian Federation of Anticoagulation Clinics).
    Poli D, Antonucci E, Zanazzi M, Grifoni E, Testa S, Ageno W, Palareti G.
    Thromb Haemost; 2012 Jun; 107(6):1100-6. PubMed ID: 22535516
    [Abstract] [Full Text] [Related]

  • 2. Gender differences of bleeding and stroke risk in very old atrial fibrillation patients on VKA treatment: results of the EPICA study on the behalf of FCSA (Italian Federation of Anticoagulation Clinics).
    Poli D, Antonucci E, Testa S, Ageno W, Palareti G, FCSA (Italian Federation of Anticoagulation Clinics).
    Thromb Res; 2013 Jan; 131(1):12-6. PubMed ID: 23141847
    [Abstract] [Full Text] [Related]

  • 3. Bleeding risk in very old patients on vitamin K antagonist treatment: results of a prospective collaborative study on elderly patients followed by Italian Centres for Anticoagulation.
    Poli D, Antonucci E, Testa S, Tosetto A, Ageno W, Palareti G, Italian Federation of Anticoagulation Clinics.
    Circulation; 2011 Aug 16; 124(7):824-9. PubMed ID: 21810658
    [Abstract] [Full Text] [Related]

  • 4. Glomerular filtration rate in patients with atrial fibrillation on warfarin treatment: a subgroup analysis from the AURICULA registry in Sweden.
    Jönsson KM, Wieloch M, Sterner G, Nyman U, Elmståhl S, Engström G, Svensson PJ.
    Thromb Res; 2011 Oct 16; 128(4):341-5. PubMed ID: 21620441
    [Abstract] [Full Text] [Related]

  • 5. Efficacy and safety of dabigatran compared with warfarin in relation to baseline renal function in patients with atrial fibrillation: a RE-LY (Randomized Evaluation of Long-term Anticoagulation Therapy) trial analysis.
    Hijazi Z, Hohnloser SH, Oldgren J, Andersson U, Connolly SJ, Eikelboom JW, Ezekowitz MD, Reilly PA, Siegbahn A, Yusuf S, Wallentin L.
    Circulation; 2014 Mar 04; 129(9):961-70. PubMed ID: 24323795
    [Abstract] [Full Text] [Related]

  • 6. Renal dysfunction in patients with heart failure with preserved versus reduced ejection fraction: impact of the new Chronic Kidney Disease-Epidemiology Collaboration Group formula.
    McAlister FA, Ezekowitz J, Tarantini L, Squire I, Komajda M, Bayes-Genis A, Gotsman I, Whalley G, Earle N, Poppe KK, Doughty RN, Meta-analysis Global Group in Chronic Heart Failure (MAGGIC) Investigators.
    Circ Heart Fail; 2012 May 01; 5(3):309-14. PubMed ID: 22441773
    [Abstract] [Full Text] [Related]

  • 7. Comparison of the prevalence and mortality risk of CKD in Australia using the CKD Epidemiology Collaboration (CKD-EPI) and Modification of Diet in Renal Disease (MDRD) Study GFR estimating equations: the AusDiab (Australian Diabetes, Obesity and Lifestyle) Study.
    White SL, Polkinghorne KR, Atkins RC, Chadban SJ.
    Am J Kidney Dis; 2010 Apr 01; 55(4):660-70. PubMed ID: 20138414
    [Abstract] [Full Text] [Related]

  • 8. Sequential changes in renal function and the risk of stroke and death in patients with atrial fibrillation.
    Guo Y, Wang H, Zhao X, Zhang Y, Zhang D, Ma J, Wang Y, Lip GY.
    Int J Cardiol; 2013 Oct 12; 168(5):4678-84. PubMed ID: 23972369
    [Abstract] [Full Text] [Related]

  • 9. Agreement between equations estimating glomerular filtration rate in elderly nursing home residents and in hospitalised patients: implications for drug dosing.
    Corsonello A, Pedone C, Lattanzio F, Semeraro R, D'Andria F, Gigante M, Coppola A, Cadeddu G, Laino I, Incalzi RA.
    Age Ageing; 2011 Sep 12; 40(5):583-9. PubMed ID: 21398293
    [Abstract] [Full Text] [Related]

  • 10. Stroke prevention in atrial fibrillation patients with chronic kidney disease.
    Hart RG, Eikelboom JW, Brimble KS, McMurtry MS, Ingram AJ.
    Can J Cardiol; 2013 Jul 12; 29(7 Suppl):S71-8. PubMed ID: 23790601
    [Abstract] [Full Text] [Related]

  • 11. Estimated glomerular filtration rate and prognosis in heart failure: value of the Modification of Diet in Renal Disease Study-4, chronic kidney disease epidemiology collaboration, and cockroft-gault formulas.
    Zamora E, Lupón J, Vila J, Urrutia A, de Antonio M, Sanz H, Grau M, Ara J, Bayés-Genís A.
    J Am Coll Cardiol; 2012 May 08; 59(19):1709-15. PubMed ID: 22554602
    [Abstract] [Full Text] [Related]

  • 12. Stroke risk and efficacy of apixaban in atrial fibrillation patients with moderate chronic kidney disease.
    Eikelboom JW, Connolly SJ, Gao P, Paolasso E, De Caterina R, Husted S, O'Donnell M, Yusuf S, Hart RG.
    J Stroke Cerebrovasc Dis; 2012 Aug 08; 21(6):429-35. PubMed ID: 22818021
    [Abstract] [Full Text] [Related]

  • 13. Old and new oral anticoagulants for venous thromboembolism and atrial fibrillation: a review of the literature.
    Becattini C, Vedovati MC, Agnelli G.
    Thromb Res; 2012 Mar 08; 129(3):392-400. PubMed ID: 22264937
    [Abstract] [Full Text] [Related]

  • 14. Simple cystatin C formula compared to sophisticated CKD-EPI formulas for estimation of glomerular filtration rate in the elderly.
    Bevc S, Hojs R, Ekart R, Gorenjak M, Puklavec L.
    Ther Apher Dial; 2011 Jun 08; 15(3):261-8. PubMed ID: 21624073
    [Abstract] [Full Text] [Related]

  • 15. Bleeding rates in patients older than 90 years of age on vitamin K antagonist therapy for nonvalvular atrial fibrillation.
    Tincani E, Baldini P, Crowther MA, Zanasi A, Ferrari P, Cenci AM, Rioli G.
    Blood Coagul Fibrinolysis; 2009 Jan 08; 20(1):47-51. PubMed ID: 20523164
    [Abstract] [Full Text] [Related]

  • 16. [Assessment of the new CKD-EPI equation to estimate the glomerular filtration rate].
    Montañés Bermúdez R, Bover Sanjuán J, Oliver Samper A, Ballarín Castán JA, Gràcia García S.
    Nefrologia; 2010 Jan 08; 30(2):185-94. PubMed ID: 20038962
    [Abstract] [Full Text] [Related]

  • 17. Chronic kidney disease following liver transplantation: a South Australian experience.
    Ramachandran J, Juneja R, John L, Dutta AK, Chen JW, Woodman RJ, Wigg AJ.
    Transplant Proc; 2010 Nov 08; 42(9):3644-6. PubMed ID: 21094832
    [Abstract] [Full Text] [Related]

  • 18. Epidemiology of chronic kidney disease in the Kingdom of Saudi Arabia (SEEK-Saudi investigators) - a pilot study.
    Alsuwaida AO, Farag YM, Al Sayyari AA, Mousa D, Alhejaili F, Al-Harbi A, Housawi A, Mittal BV, Singh AK.
    Saudi J Kidney Dis Transpl; 2010 Nov 08; 21(6):1066-72. PubMed ID: 21060175
    [Abstract] [Full Text] [Related]

  • 19. The predictive ability of bleeding risk stratification models in very old patients on vitamin K antagonist treatment for venous thromboembolism: results of the prospective collaborative EPICA study.
    Poli D, Antonucci E, Testa S, Cosmi B, Palareti G, Ageno W, FCSA Italian Federation of Anticoagulation Clinics.
    J Thromb Haemost; 2013 Jun 08; 11(6):1053-8. PubMed ID: 23578305
    [Abstract] [Full Text] [Related]

  • 20. Oral anticoagulation in chronic kidney disease: A huge challenge.
    Roldán V, Marín F.
    Thromb Haemost; 2012 Jul 08; 108(1):3-5. PubMed ID: 22628077
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.